Icra sees pharma industry growth tapering to 7-10% over FY18-FY20Post published:July 4, 2017Post category:Industry NewsThe Indian pharma industry is likely to witness a slowdown in growth because of pricing pressure and regulatory interventions in the US, according to an Icra report Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostIndoStar Capital close to acquiring ICICI Home Finance Next PostGST rates: Footwear to cost more as firms look to increase prices by 5-7% You Might Also Like H1B visa reforms effect: Infosys to hire 10,000 US workers May 2, 2017 Siemens releases Ruggedcom RST2228 Layer 2 rack switch January 23, 2018 The Industrial Automation Transformation Change Agent – Inside Inductive Automation’s ICC 2019 Conference November 19, 2019
The Industrial Automation Transformation Change Agent – Inside Inductive Automation’s ICC 2019 Conference November 19, 2019